Literature DB >> 9506920

Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells.

E L Becker1, F A Forouhar, M L Grunnet, F Boulay, M Tardif, B J Bormann, D Sodja, R D Ye, J R Woska, P M Murphy.   

Abstract

The formylpeptide receptor (FPR), previously found only on polymorphonuclear leukocytes and monocytes/macrophages, responds to both synthetic N-formyl oligopeptides and those produced by bacteria. The cDNA for human FPR has been cloned and a rabbit polyclonal antiserum directed against a synthetic 11-amino-acid peptide corresponding to the deduced carboxy-terminus has been produced. We have now extensively characterized and used the antibody to detect FPR on normal human tissues and cell types. The receptor antigen is present on some epithelial cells, especially those with a secretory function, and on some endocrine cells, e.g., follicular cells of the thyroid and cortical cells of the adrenal. Liver hepatocytes and Kupffer cells are positive. Smooth muscle and endothelial cells are also generally positive. In the brain and spinal cord, the neurons of the motor, sensory, and cerebellar systems, and those of the parasympathetic and sympathetic systems stain positively. These data suggest that the putative endogenous agonist for FPR or an antigenically similar receptor reacts with cellular targets in the neuromuscular, vascular, endocrine, and immune systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506920     DOI: 10.1007/s004410051042

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  35 in total

Review 1.  Expression and signaling of formyl-peptide receptors in the brain.

Authors:  Fabio Cattaneo; Germano Guerra; Rosario Ammendola
Journal:  Neurochem Res       Date:  2010-11-02       Impact factor: 3.996

Review 2.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

Review 3.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

4.  Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1.

Authors:  Ji-Liang Gao; Erich H Schneider; Eugene L Dimitrov; Forrest Haun; Therese M Pham; Abdul H Mohammed; Ted B Usdin; Philip M Murphy
Journal:  Behav Genet       Date:  2011-04-12       Impact factor: 2.805

5.  The mechanism underlying the contractile effect of a chemotactic peptide, formyl-Met-Leu-Phe on the guinea-pig Taenia coli.

Authors:  Hiroshi Kawata; Katsuya Hirano; Junji Nishimura; Chiharu Kubo; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

6.  Strain-dependent genomic factors affect allergen-induced airway hyperresponsiveness in mice.

Authors:  Samir N P Kelada; Mark S Wilson; Urraca Tavarez; Kari Kubalanza; Bhavesh Borate; Greg S Whitehead; Shuichiro Maruoka; Michelle G Roy; Michelle Olive; Danielle E Carpenter; David M Brass; Thomas A Wynn; Donald N Cook; Christopher M Evans; David A Schwartz; Francis S Collins
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-04       Impact factor: 6.914

7.  The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.

Authors:  Erich H Schneider; Joseph D Weaver; Sonia S Gaur; Brajendra K Tripathi; Algirdas J Jesaitis; Peggy S Zelenka; Ji-Liang Gao; Philip M Murphy
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

8.  Characterization of the human fMLP receptor in neutrophils and in Xenopus oocytes.

Authors:  Sigrid Wittmann; Dieter Fröhlich; Stephen Daniels
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 9.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

10.  FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages.

Authors:  Wenyan Wang; Ting Li; Xiaolin Wang; Wanxiong Yuan; Yingying Cheng; Heyu Zhang; Enquan Xu; Yingmei Zhang; Shuang Shi; Dalong Ma; Wenling Han
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.